000 -LEADER |
fixed length control field |
04010nam a22004935i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20140310150250.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
110104s2011 ne | s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9789400702776 |
|
978-94-007-0277-6 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
QR251-255 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
616.96 |
Edition number |
23 |
264 #1 - |
-- |
Dordrecht : |
-- |
Springer Netherlands, |
-- |
2011. |
912 ## - |
-- |
ZDB-2-SBL |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Jha, T.K. |
Relator term |
editor. |
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
Title |
Kala Azar in South Asia |
Medium |
[electronic resource] : |
Remainder of title |
Current Status and Challenges Ahead / |
Statement of responsibility, etc |
edited by T.K. Jha, E. Noiri. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
X, 290p. |
Other physical details |
online resource. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Preface -- Section 1: Introduction into Kala-Azar -- 1. Geography -- 2. Pathology and Mechanism of Kala-azar & PKDL -- 3. Diagnosis and Treatment of Kala-azar & PKDL -- Section 2: Therapeutic Strategy to Deal with Emergence of Drug Resistance -- 4. Epidemiology of Drug-Resistant Kala-azar in India and neighboring countries -- 5. Therapeutic Strategy for treatment of VL in drug resistant regions -- 6. Need for combination therapy to control kala-azar in South Asia -- Section 3: Diagnostic Strategy Enhancing Kala-azar Elimination Program -- 7. Challenges to visceral leishmaniasis diagnosis in the Indian sub-continent -- 8. Potentiality of urinary tests to kala-azar disease management -- 9. Use of LAMP as a practical field tool for diagnosis of Kala-azar -- Section 4: PKDL and its Implications in Eliminating Kala-azar -- 10. Polymorphism of kala azar in South Asia -- 11. Post kala-azar dermal leishmaniasis (PKDL): Facing the challenge for eliminating kala-azar from South Asia -- Section 5: New challenges confronting Kala azar Elimination Programme and their possible solutions -- 12. Climate change and kala-azar -- 13. Role of policy makers in achieving the target for kala azar elimination in South Asia – the Bangladesh experience. |
520 ## - SUMMARY, ETC. |
Summary, etc |
Therapeutic regimens for visceral leishmaniasis (also Kala-azar, Dum-dum fever or black fever), caused by parasitic protozoa of the Leishmania genus, evolve at a pace never seen before. Spread by tiny and abundant sand flies, the parasite infects internal organs and bone marrow and if left untreated will almost always result in the death of the host. In developing countries successful diagnosis and treatment are complicated by asymptomatic cases, undernutrition and Kala-azar/HIV co-infections. This book brings together world-renown experts writing state-of-arts review on the progress in diagnosis and treatment of visceral leishmaniasis, ultimately leading to the complete elimination of this fatal disease from South Asia. The chapters provide valuable information for disease control as well as therapy and the diagnostic improvements necessary for early treatment, subclinical detection and drug-resistant cases. The presented methods allow for points-of-care testing in the endemic area, enabling rapid detection in resource-poor settings with easy handling and low costs. This book provides essential information for scientists, medical practitioners and policy makers involved in the diagnosis, treatment and elimination of Kala-azar. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine. |
|
Topical term or geographic name as entry element |
Medical laboratories. |
|
Topical term or geographic name as entry element |
Drug interactions. |
|
Topical term or geographic name as entry element |
Medical parasitology. |
|
Topical term or geographic name as entry element |
Nephrology. |
|
Topical term or geographic name as entry element |
Veterinary medicine. |
|
Topical term or geographic name as entry element |
Biomedicine. |
|
Topical term or geographic name as entry element |
Parasitology. |
|
Topical term or geographic name as entry element |
Drug Resistance. |
|
Topical term or geographic name as entry element |
Veterinary Medicine. |
|
Topical term or geographic name as entry element |
Laboratory Medicine. |
|
Topical term or geographic name as entry element |
Nephrology. |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Noiri, E. |
Relator term |
editor. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY |
Title |
Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Display text |
Printed edition: |
International Standard Book Number |
9789400702769 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-94-007-0277-6 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Item type |
E-Book |